News

Understanding the Latest Options Trading Actions for Vistra Corp

Understanding the Latest Options Trading Actions for Vistra Corp

Market Sentiment Around Vistra Corporation

Significant investors, often referred to as whales, have recently taken a decidedly bearish position regarding Vistra Corp. This sentiment reflects their outlook on the market and future price movements.

Overview of Recent Options Trades for Vistra

Upon examining the options trading history for Vistra (NYSE: VST), we identified a total of 11 recorded trades. An analysis reveals that approximately 36% of these investors initiated trades with bullish predictions, while a higher percentage, 54%, entered trades anticipating a bearish outcome.

Analyzing Price Movement Expectations

When we delve into volume and open interest associated with these contracts, it becomes evident that large investors have been focusing on a price target between $80.0 and $185.0 for Vistra in the past quarter.

Understanding Volume and Open Interest Trends

Volume and open interest serve as valuable indicators for those conducting thorough due diligence on stocks. By observing these metrics, traders can gauge the liquidity and overall interest in options for specific strike prices.

In the prior 30 days, we can evaluate the fluctuating volume and open interest concerning both call and put options for whale-related activity surrounding Vistra within the identified price range.

What Recent Options Activity Reveals

We recently categorized significant options trades associated with Vistra, presenting the information in an easy-to-digest format. Notably, the options trades indicate a mix of bullish and bearish sentiments from large market participants.

Snapshot of Noteworthy Options Activity

Below is a table that summarizes specific instances of insightful options trading activities for Vistra:

Symbol PUT/CALL Trade Type Investor Sentiment Expiration Date Ask Price Bid Price Trade Price Strike Price Total Trade Value Open Interest Volume
VST PUT TRADE BEARISH 01/15/27 $29.15 $26.95 $28.50 $160.00 $142,500 916 50
VST CALL TRADE BULLISH 01/15/27 $89.00 $86.50 $89.00 $80.00 $89,000 33 10
VST CALL TRADE BEARISH 01/15/27 $72.95 $72.00 $72.00 $100.00 $72,000 198 10
VST CALL SWEEP BULLISH 01/16/26 $3.95 $3.90 $3.95 $170.00 $45,800 1,600 326
VST PUT TRADE BEARISH 01/15/27 $43.20 $43.20 $43.20 $185.00 $43,200 391 10

Current Standing of Vistra Corp

Currently, Vistra Corp is experiencing a trading volume of 335,839, with its share price up by 0.98%, now sitting at $163.26. The relative strength index (RSI) indicates that the stock maintains a neutral stance, balancing between overbought and oversold conditions. Furthermore, investors can expect the next earnings report in just a short while.

Expert Analysts' Outlook on Vistra

Recently, one professional analyst conveyed their thoughts on the stock, projecting an average price target of $233. This positive outlook demonstrates confidence in Vistra’s potential for growth.

As options trading carries inherent risks compared to direct stock trading, it is crucial for traders to remain educated, implement strategies such as gradual entry and exit on trades, and closely monitor market developments.

Frequently Asked Questions

What is the main sentiment among large investors regarding Vistra?

The majority of large investors currently express a bearish outlook toward Vistra, as indicated by recent options trades.

How much trading activity has been recorded for Vistra's options?

Recently, there have been 11 notable trades in Vistra's options market.

What price range have investors been targeting for Vistra?

Investors have been focusing on a target price between $80.0 and $185.0 for Vistra over the last three months.

What are the expectations for Vistra's next earnings report?

Investors can expect the next earnings report to be available in approximately 59 days.

What do analysts project for Vistra's price target?

One analyst has set a price target of $233.0 for Vistra, reflecting a positive sentiment for the company’s future performance.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 11

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 17

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 9

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 8

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 11

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 19

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 19

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading

Top 5 Most Recently Viewed Articles

America's Car-Mart Secures $300 Million Loan for Growth

Updated Category News Views 255

America's Car-Mart Secures Funding for Future Growth America's Car-Mart, Inc. (NASDAQ: CRMT), a leading automotive retailer, has taken a strategic step by closing a significant five-year, $300 million term loan. This loan, managed by the seasoned professionals at Silver Point Capital, L.P., aims to enhance the company’s capital structure and support its long-term growth...

Continue Reading
IASO Bio's Breakthrough Drug Application Acceptance in Singapore

Updated Category News Views 251

IASO Bio’s Major Step Forward with New Drug Application IASO Biotherapeutics, a pioneering biopharmaceutical company dedicated to the advancement of innovative cell therapies and biologics, has reached a significant milestone. The Singapore Health Sciences Authority (HSA) has officially accepted the New Drug Application (NDA) for Equecabtagene Autoleucel, known as...

Continue Reading
Creating Community Leaders: National Heritage Academies and United Way

Updated Category News Views 150

Empowering Students to Make a Difference The student-led organization is providing career opportunities while connecting with the community. National Heritage Academies® (NHA) is thrilled to celebrate its collaboration with United Way through the Student United Way program. This initiative equips high school students with essential tools and opportunities to enact...

Continue Reading
Future Growth of Augmented and Virtual Reality Technologies

Updated Category News Views 259

Exploring the Growth of Augmented Reality and Virtual Reality Market The global market for Augmented Reality (AR) and Virtual Reality (VR) is on the rise, with expectations of substantial growth over the next few years. Analysts estimate that this sector will expand by approximately USD 442.99 billion between 2024 and 2028. The compound annual growth rate (CAGR) for this...

Continue Reading
ImmVira Launches Innovative Exosome, Transforming Cosmetics

Updated Category News Views 407

ImmVira Leads the Way with Groundbreaking Exosome Technology In a remarkable advancement for the cosmetic industry, ImmVira Group has announced its innovative product, MVR-EX103, an engineered exosome specifically developed for treating superficial skin depressions. This development marks a pivotal moment, as it has successfully acquired the International Nomenclature...

Continue Reading